Carolinas HealthCare System
In this Section

Institutional Review Board (IRB)

Carolinas HealthCare System (CHS) Institutional Review Board operates under the guidance of the Ethical Principles and Guidelines for the Protection of Human Subjects of Research. This report, commonly referred to as the Belmont Report, contains ethical principles regarding all research involving human subjects as identified by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. All sites within CHS are required by CHS to conform to ethical principles of the highest standard as may be determined by the Department of Health and Human Services (DHHS) or Office of Civil Rights (OCR).

Prior to the initiation of any human subject involvement in research within CHS, the IRB must review:

  • Risks to subjects
  • Anticipated benefits to subjects and others potentially affected by the research
  • Specific process of informed consent to be employed

The CHS IRB also serves as the Health Insurance Portability and Accountability Act (HIPAA) Privacy Board for the review of clinical research based on federal HIPAA regulations.

The CHS IRB consists of two committees, each of which meets monthly. The committees are composed of highly qualified individuals with scientific and non-scientific backgrounds, educated in and dedicated to ensuring the protection of human subjects in the conduct of clinical trials.

The IRB is experienced in the review of:

  • Food and Drug Administration (FDA) and Office for Human Research Protection (OHRP) Regulated Studies 
  • Phase I-IV drug studies in all therapeutic areas 
  • Device Studies
  • Biologic Studies
  • Observational/Registry Studies
  • Social-Behavioral Studies

CHS IRB complies with all federal regulations pertaining to the protection of human research subjects. CHS has a Federal Wide Assurance (FWA) and each IRB is registered with the OHRP.

FWA: 00000387  IORG: 0000740  

IRB registration:
Committee A - IRB00001088
Committee B - IRB00001103

Since 2006 Carolinas HealthCare System has outsourced IRB review of Phase III/IV industry-sponsored Drug Trials research to Copernicus Group IRB, an independent IRB. 

Since 2012, Carolinas HealthCare System has outsourced IRB review of Levine Cancer Institute Oncology Clinical Trials to Chesapeake IRB, an independent IRB.

Contact Information:

Jane Flax, Staff Assistant
Institutional Review Board
704-355-3158 

About Carolinas HealthCare System
Who We Are
Leadership
Community Benefit
Corporate Financial Information
Diversity & Inclusion
Annual Report
Foundation
Patient Links
Pay Your Bill
Hospital Pre-Registration
Patient Rights
Privacy Policy
Financial Assistance
Quality & Value Reports
Insurance
Careers
Join Carolinas HealthCare System
Physician Careers

For Employees
Carolinas Connect
Connect with Us
Watch Carolinas HealthCare on YoutubeFollow Carolinas HealthCare on TwitterLike Carolinas HealthCare on FacebookContact Carolinas HealthCareJoin Carolinas HealthCare on LinkedInGo to our mobile website.